CIK: 1207633 - Address: C/o Aerie Pharmaceuticals, Inc., 4301 Emperor Blvd., Suite 400, Durham, NC 27703
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret218-2-5-35015918163
P%wins633850100757567

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

9/9/19 17:43
9/9/19
AERIAerie Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagAnido Vicente JrNCDOCEOP49919.0102615198D
11/1/13 19:03
10/30/13
AERIAerie Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagAnido Vicente JrNJDOCEOP28010.00728New28D03-196247140
2/27/09 10:58
2/25/09
ISTAIsta Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAnido Vicente JrCADOP,CEOP.m611.980319390-26-16-162819171
2/26/09 13:44
2/24/09
ISTAIsta Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAnido Vicente JrCADOP,CEOP.m991.9505117359-5-6-43519776
12/12/08 16:34
12/11/08
ISTAIsta Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAnido Vicente JrCADOP,CEOP60.8415083253D-86-82-58-31271264876-18-24-1966260369
12/12/08 09:31
12/11/08
ISTAIsta Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAnido Vicente JrCADOP,CEOP820.991008351246D-86-82-58-312712648768-16-1175268377
12/11/08 15:56
12/9/08
ISTAIsta Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAnido Vicente JrCADOP,CEOP.m660.6769098151163D-88-86-64-46884303421115128338463
5/13/05 12:47
5/12/05
ISTAIsta Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAnido Vicente JrCADOP,CEOP.d147.59121613D86-45-26-25-182-2-121024-16-24
5/13/05 12:15
5/12/05
ISTAIsta Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticAnido Vicente JrCADOP,CEOP.d887.63112New12D86-45-26-25-182-2-121024-16-24
2/25/04 16:45
2/20/04
AHGApria Healthcare Group IncDEHealthHealthHome Health Care ServicesAnido Vicente JrCADP.a3130.6601334D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact